Aspen Pharmacare’s decision to stop manufacturing COVID-19 vaccines in South Africa is partly a lesson in why action is needed to create sustainable demand and market certainty for domestically produced medicines and vaccines on the African continent, according to experts in global trade and development.
Aspen Setback Illustrates Need For Africa To Build Up Vaccines Market
A coordinated effort will be needed if Africa is to increase its manufacturing capacity and ensure a market for domestically produced vaccines.
